Abstract
The response of pregnant marmosets (Callithrix jacchus) to the thalidomide derivative EM 12 was evaluated. EM 12 was selected for these studies because it is more active than thalidomide and is much more stable for hydrolysis. Skeletal gross structural abnormalities were observed when EM 12 was given to marmosets for 3–7 days during the period between days 49 and 60 post ovulation. Using the treatment schedule finally adapted in our laboratory, i.e. treatment during days 51–57 post ovulation, doses of 5 (or 10) mg EM 12/kg body wt induced the typical limb abnormalities known from man with an 80–100% certainty. In some animals we could observe the typical pattern of abnormalities even with doses as low as 1 mg EM 12/kg body wt. Abnormalities of the skeleton induced during this sensitive period are described. None of these (except some bifurcations of ribs) were seen in any of the ten litters (23 fetuses) serving as controls during the period of the study.
Similar content being viewed by others
References
Burley DM (1962) Thalidomide and congenital abnormalities. Lancet 1: 271
Butler H (1977) The effect of thalidomide on a prosimian: the greater galago (galago crassicaudatus). J Med Primatol 6: 319–324
Csato W (1987) Die Embryonalentwicklung bei Callithrix jacchus von Stadium 6 bis 12. Z Anat Entwicklungsgesch (in press)
Delahunt CS, Lassen LJ (1964) Thalidomide syndrome in monkeys. Science 146: 1300–1305
Diewert VM, Pratt RM (1979) Selective inhibition of mandibular growth and induction of cleft palate by Diazo-oxo-norleucin (DON) in the rat. Teratology 20: 37–52
Felisati D (1964) Teratogenic action of thalidomide. Lancet 1: 724
Frommert J, Margolis MR (1971) Contribution of Meckel's cartilage to ossification of the mandible in mice. J Dtsch Res 50: 1260–1265
Heger HW, Neubert D (1983) Timing of ovulation and implantation in the common marmoset, Callithrix jacchus, by monitoring estrogens and 6β-hydroxypregnanolone in urine. Arch Toxicol 54: 41–52
Heger HW, Neubert D (1987) Determination of ovulation and pregnancy in the marmoset (Callithrix jacchus) by monitoring of urinary hydroxypregnanolone excretion. J Med Primatol 16: 151–164
Heger HW, Enkemann B, Bremer D, Barrach H-J, Merker H-J, Neubert D (1985) Studies on the teratogenic effect of EM-12 using marmoset monkeys. Teratology 32: 22A-23A
Helm F (1966) Tierexperimentelle Untersuchungen und Dysmeliesyndrom. Arzneimittelforsch 16: 1232–1244
Helm FC, Frankus E (1982) Chemical structure and teratogenic activity of thalidomide-related compounds. Teratology 25: 47A
Helm FC, Frankus E, Friderichs E, Graudums I, Flohé L (1981) Comparative teratological investigation of compounds structurally and pharmacologically related to thalidomide. Arzneimittelforsch 31: 941–949
Hendrickx AG (1971) Teratogenicity of thalidomide in the baboon (Papio cynocephalus), bonnet monkey (Macaca radiata) and cynomolgus monkey (Macaca irus). In: Proceedings of the 3rd International Congress on Primatology, Zürich 1970. Basel, Karger, vol 2, pp 230–237
Hendrickx AG (1972) A comparison of temporal factors in the embryological development of man, old world monkeys and galagos, and craniofacial malformations induced by thalidomide and triamcinolone. In: Goldsmith EI, Moor-Jankowski J (eds) Medical Primatology. Karger, Basel, pp 259–269
Hendrickx AG (1973) The sensitive period and malformation syndrome produced by thalidomide in the crab-eating monkey (Macaca fascicularis). J Med Prim 2: 267–276
Hendrickx AG, Newman L (1973) Appendicular skeletal and visceral malformations induced by thalidomide in bonnet monkeys. Teratology 7: 151–160
Hendrickx AG, Houston ML, Kraemer DC, Gasser RF, Bollert JA (1971) Embryology of the baboon. Univ of Chicago Press, Chicago
Hendrickx AG, Sawyer RH, Lasley BL, Barnes RD (1975) Comparison of developmental stages in primates with a note on the detection of ovulation. Lab Anim Handbooks 6: 305–315
Hiddleston WA (1976) Large scale production of a small laboratory primate — Callithrix jacchus. In: Antikatzides, Erichsen, Spiegel (eds) The Laboratory Animal in the Study of Reproduction. Fischer Verlag, Stuttgart, pp 51–57
Hiddleston WA, Siddall RA (1978) The production and use of Callithrix jacchus for safety evaluation studies. In: Neubert D, Merker H-J, Nau H, Langman J (eds) Role of Pharmacokinetics in Prenatal and Perinatal Toxicology. Thieme, Stuttgart, pp 289–297
Horstmann W (1966) Hinweise auf zentralnervöse Schäden im Rahmen der Thalidomid-Embryopathie. Z Kinderheilkd 96: 291–307
Kajii T, Kida M, Takahashi K (1973) The effect of thalidomide intake during 113 human pregnancies. Teratology 8: 163–166
Kida M (1987) Thalidomide embryopathy in Japan. Kodansha Ltd, Tokyo
Kreipe U (1968) Mißbildungen innerer Organe bei Thalidomidembryopathie. Arch Kinderheilkd 176: 33–61
Lehmann H, Niggeschulze A (1971) The teratologie effects of thalidomide in Himalayan rabbits. Toxicol Appl Pharmacol 18: 208–219
Lenz W, Knapp K (1962) Thalidomide embryopathy. Arch Environ Health 5: 100–105
Livingstone G (1965) Congenital ear abnormalities due to thalidomide. Proc R Soc Med 58: 493–497
Mellin GW, Katzenstein M (1962) The saga of thalidomide; neuropathy to embryopathy, with case reports of congenital anomalies. N Engl J Med: 1184–1192 and 1238–1244
Miehlke A, Partsch CJ (1963) Ohrmißbildungen, Facialis- und Abducenslähmung als Syndrom der Thalidomidschädigung. Arch Ohr- Nas- u Kehlk-Heilkd 181: 154–174
Moore HDM, Gems S, Hearn ID (1985) Early implantation stages in the marmoset monkey (Callithrix jacchus). Am J Anat 172: 265–278
Neubert D, Blankenburg G, Chahoud I, Franz G, Herken R, Kastner M, Klug S, Kroger J, Krowke R, Lewandowski C, Merker H-J, Schulz T, Stahlmann R (1986) Results of in vivo and in vitro studies for assessing prenatal toxicity. Environ Health Perspect 70: 89–103
Neubert D, Heger W, Merker H-J, Sames K, Meister R (1987a) Embryotoxic effects of thalidomide derivatives in the non-human primate — Callithrix jacchus: II. Elucidation of the susceptible period and of the variability of embryonic stages. Arch Toxicol 61: 180–191
Neubert D, Chahoud I, Platzek T, Meister R (1987b) Principles and problems in assessing prenatal toxicity. Arch Toxicol 60: 238–245
Neubert D, Bochert G, Platzek T, Chahoud I, Fischer B, Meister R (1987 c) Dose-response relationships in prenatal toxicity. Congen Anomal (in press)
Nishimura H (1972) A note on critical periods for drug induced reduction deformities of total forelimbs in man. Congen Anomal 12: 191–193
Nishimura H, Takano K, Tanimura T, Yasuda M (1968) Normal and abnormal development of human embryos: first report of the analysis of 1213 intact embryos. Teratology 1: 281–290
Nowack E (1965) Die sensible Phase der Thalidomid-Embryopathie. Humangenetik 1: 516–536
O'Rahilly R, Gardner E (1975) The timing and sequence of events in the development of the limbs in the human embryo. Anat Embryol 148: 1–23
Pearn JH, Vickers TH (1965) The rabbit thalidomide embryopathy. Br J Exp Pathol 47: 186–195
Pfeiffer RA, Kosenow W (1962) Zur Frage einer exogenen Verursachung von schweren Extremitätenmißbildungen. Münch Med Wochenschr 104: 68–74
Platzek T, Meister R, Chahoud I, Bochert G, Krowke R, Neubert D (1987) Studies on the mechanisms and dose-response relationships of Prenatal Toxicity. In: Welsch F (ed) Mechanism of Prenatal Toxicity. Hemisphere Publ. Co, Washington, New York, pp 59–81
Pliess G (1962) Thalidomide and congenital abnormalities. Lancet 1: 1128–1129
Poswillo DE, Hamilton WJ, Sopher D (1972) The marmoset as an animal model for teratological research. Nature 239: 460–462
Sames K, Heger W, Neubert D, Klug S, Merker H-J (1987) The relationship between stage and time during the stages 11 to 23 in marmosets (Callithrix jacchus), with special reference to the limb development. Acta Anat (in press)
Schübel F, Partsch CJ (1965) Thalidomid-Embryopathien und ihre Einwirkung auf die Zahnanlage. Dtsch Zahnärztl Z 20: 1278–1283
Schumacher HJ, Terapane JF, Jordan RL, Wilson JG (1972) The teratogenic activity of a thalidomide analogue, EM 12, in rabbits, rats and monkeys. Teratology 5: 233–240
Seller MJ (1962) Thalidomide and congenital abnormalities. Lancet 1: 249
Siddall RA (1978) The use of marmosets Callithrix jacchus in teratological and toxicological research. Prim Med 10: 215–224, Karger, Basel
Smithells RW (1973) Defects and disabilities of thalidomide children. Br Med J 1: 269–272
Somers GF (1962) Thalidomide and congenital abnormalities. Lancet 1: 912–913
Somers GF (1963) The foetal toxicity of thalidomide. Effects of drugs on the foetus. Excerpt Med 1: 49–58
Stahl A (1967) Dysplasien im Bereich des Mundes, der Kiefer und der Zähne bei Dysmelie. Dtsche Zahnärztl Zeitschr 22: 356–367
Staples RE, Holtkamp DE (1963) Effects of parental thalidomide treatment on gestation and fetal development. Exp Mol Pathol Suppl 2: 81–106
Westermann U, Merker H-J (1980) Morphologische Untersuchungen zur Microgenie-Entstehung bei der Ratte. Dtsch Z Mund- Kiefer- Gesichtschir 4: 75–78
Wiedemann HR (1961) Hinweis auf eine derzeitige Häufung hypo- und aplastischer Fehlbildungen der Gliedmassen. Med Welt 37: 1863–1866
Willert HG, Henkel HL (1969) Klinik und Pathologie der Dysmelie. Springer, Berlin Heidelberg New York
Wilson JG (1966) Teratogeny in nonhuman primates. In: Miller CO (ed) Proceedings of a Conference on Nonhuman Primate Toxicology, FDA, Washington, pp 114–123
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Merker, HJ., Heger, W., Sames, K. et al. Embryotoxic effects of thalidomide-derivatives in the non-human primate Callithrix jacchus . Arch Toxicol 61, 165–179 (1988). https://doi.org/10.1007/BF00316631
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00316631